Association between Inhaled β(2)-agonists Initiation and Risk of Major Adverse Cardiovascular Events: A Population-based Nested Case-Control Study

PURPOSE: Despite ample evidence underpinning the efficacy of β(2)-agonists in asthma and chronic obstructive pulmonary disease (COPD), the occurrence of β(1)- and β(2)-adrenoceptors in the heart suggests that β(2)-agonists may have deleterious cardiac effects. We investigated the association between...

Descripción completa

Detalles Bibliográficos
Autores principales: Amegadzie, Joseph Emil, Gamble, John-Michael, Farrell, Jamie, Gao, Zhiwei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9130098/
https://www.ncbi.nlm.nih.gov/pubmed/35645559
http://dx.doi.org/10.2147/COPD.S358927

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9130098/
https://www.ncbi.nlm.nih.gov/pubmed/35645559
http://dx.doi.org/10.2147/COPD.S358927

Ejemplares similares